Management and outcomes of ruptured, perforated or fistulized tumors of mesenchymal origin.
emergency
optimize
outcomes
rupture
sarcoma
Journal
Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
12
09
2019
accepted:
02
12
2019
pubmed:
18
12
2019
medline:
6
2
2020
entrez:
18
12
2019
Statut:
ppublish
Résumé
Patients with ruptured, perforated or fistulized (RPF) sarcomas commonly have issues such as sepsis and malnutrition and are usually unsuitable for oncologic resection in the emergency setting. We present our approach for managing a series of patients and the outcomes which were achieved with multidisciplinary care. We reviewed records of patients referred to the section of sarcoma surgical oncology. Clinicopathologic factors, preoperative and operative interventions as well as short-term oncologic outcomes were assessed. Sixteen patients were identified between 1 January 1998 to 31 December 2018. Median age was 42.8 years. Histologies were; Gastrointestinal stromal tumors (7), desmoid (4), spindle cell tumor (2), dedifferentiated liposarcoma (2), and nonseminomatous germ cell tumor (1). Five patients had preoperative sepsis, 8 received antimicrobials, and 50% required hospitalization with a median stay of 21 days. Total parenteral nutrition was administered to 5 (31.3%) patients. Median tumor size and estimated blood loss were 13.1 cm and 350 mL respectively. No perioperative mortality occurred. Two patients have expired at a median follow-up of 16.1 months. Preoperative optimization, including the use of percutaneous drains, and antibiotics to control sepsis, where necessary, can lead to eventual oncologic resection with acceptable morbidity and no short-term mortality for patients with RPF sarcomas.
Sections du résumé
BACKGROUND
BACKGROUND
Patients with ruptured, perforated or fistulized (RPF) sarcomas commonly have issues such as sepsis and malnutrition and are usually unsuitable for oncologic resection in the emergency setting. We present our approach for managing a series of patients and the outcomes which were achieved with multidisciplinary care.
METHODS
METHODS
We reviewed records of patients referred to the section of sarcoma surgical oncology. Clinicopathologic factors, preoperative and operative interventions as well as short-term oncologic outcomes were assessed.
RESULTS
RESULTS
Sixteen patients were identified between 1 January 1998 to 31 December 2018. Median age was 42.8 years. Histologies were; Gastrointestinal stromal tumors (7), desmoid (4), spindle cell tumor (2), dedifferentiated liposarcoma (2), and nonseminomatous germ cell tumor (1). Five patients had preoperative sepsis, 8 received antimicrobials, and 50% required hospitalization with a median stay of 21 days. Total parenteral nutrition was administered to 5 (31.3%) patients. Median tumor size and estimated blood loss were 13.1 cm and 350 mL respectively. No perioperative mortality occurred. Two patients have expired at a median follow-up of 16.1 months.
CONCLUSION
CONCLUSIONS
Preoperative optimization, including the use of percutaneous drains, and antibiotics to control sepsis, where necessary, can lead to eventual oncologic resection with acceptable morbidity and no short-term mortality for patients with RPF sarcomas.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
474-479Informations de copyright
© 2019 Wiley Periodicals, Inc.
Références
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7-34.
Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-M156.
Kitabayashi K, Seki T, Kishimoto K, et al. A spontaneously ruptured gastric stromal tumor presenting as generalized peritonitis: report of a case. Surg Today. 2001;31:350-354.
Nishibe M, Nishibe T, Yamashita T, Kaji M, Fukuhara I, Yasuda K. Perforated leiomyosarcoma of Meckel's diverticulum: report of a case. Surg Today. 2001;31:163-165.
Yamashita D, Usami Y, Toyosawa S, Hirota S, Imai Y. A case of diffuse infiltrating gastrointestinal stromal tumor of sigmoid colon with perforation. Pathol Int. 2014;64:34-38.
Chen Y, Hao J, Yang Y, Yang J, Hao X. Tumor rupture predicts early metastasis and poor prognosis in stage III soft tissue sarcomas. World J Surg. 2011;35:1002-1009.
Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27:31-37.
Hohenberger P, Ronellenfitsch U, Oladeji O, et al. Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour. Br J Surg. 2010;97:1854-1859.
Hølmebakk T, Bjerkehagen B, Boye K, Bruland Ø, Stoldt S, Sundby Hall K. Definition and clinical significance of tumour rupture in gastrointestinal stromal tumours of the small intestine. Br J Surg. 2016;103:684-691.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
Burmas M, Aitken RJ, Broughton KJ. Outcomes following emergency laparotomy in Australian public hospitals. ANZ J Surg. 2018;88:998-1002.
Symons NRA, Moorthy K, Almoudaris AM, et al. Mortality in high-risk emergency general surgical admissions. Br J Surg. 2013;100:1318-1325.
Asare EA, Feig BW. Raining frogs, flying horses, and defining tumor rupture in GIST. Ann Surg Oncol. 2019;26:1601-1603.
Stukan M. Drainage of malignant ascites: patient selection and perspectives. Cancer Manag Res. 2017;9:115-130.
Easson AM, Bezjak A, Ross S, Wright JG. The ability of existing questionnaires to measure symptom change after paracentesis for symptomatic ascites. Ann Surg Oncol. 2007;14:2348-2357.
Chapman WC, Sharp KW, Weaver F, Sawyers JL. Tumor seeding from percutaneous biliary catheters. Ann Surg. 1989;209:708-713.
Noro T, Ohdaira H, Takizawa R, Kawasaki N, Kitajima M, Suzuki Y. Metastasis to the skin at the drain site after complete resection of the lower bile duct cancer: report of a case. Surg Today. 2012;42:1248-1252.
Almond LM, Gronchi A, Strauss D, Jafri M, Ford S, Desai A. Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma. Eur J Surg Oncol. 2018;44:571-579.
Pasquali S, Gronchi A. Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications. Ther Adv Med Oncol. 2017;9:415-429.
García-Del-Muro X, López-Pousa A, Maurel J, et al. Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish group for research on sarcomas study. J Clin Oncol. 2011;29:2528-2533.
Gray GE, Meguid MM. Can total parenteral nutrition reverse hypoalbuminemia in oncology patients? Nutrition. 1990;6:225-228.
Karlawish J, Craig RM, Koretz R. The effect of total parenteral nutrition on serum albumin. J Clin Gastroenterol. 1994;19:300-302.
Nishida T, Hølmebakk T, Raut CP, Rutkowski P. Defining tumor rupture in gastrointestinal stromal tumor. Ann Surg Oncol. 2019;26:1669-1675.